TD Cowen Maintains Buy on Versigent, Raises Price Target to $49

Benzinga Newsdesk www.benzinga.com Positive 72.2%

Neg 0% Neu 0% Pos 72.2%

TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $47 to $49.

Comments

No comments yet. Be the first!